Abstract
Sickle cell anaemia is the most devastating monogenic disease throughout the world carrying autosomal recessive inheritance. Easily accessible and affordable medicinal plants play the crucial role in the primary treatment of the disease. This study comprises of twelve such medicinal plants having secondary metabolites and their effect on the sickling reversal in vitro, with their antioxidant properties. The antisickling activity of aqueous extracts of plants was calculated at different concentrations (250, 500, 1000 μg/ml). Fifty sickled and fifty normal subjects were involved with their written consents. The spectrophotometrical analysis of antioxidants were determined enzymatically and non-enzymatically at different concentrations. All the plants were found capable of inhibiting RBC hemolysis and sickling but S8 (M. charantia) extract recorded prevention from the hemolysis and antisickling activity at 250 μg/ml and also possess antioxidants. Apart from S8 extract, S12 (S. bicolor), S2 (A. sativum) and S6 (C. sinensis) have also recorded higher antisickling activity and extracts of S2 (A.sativum), S3 (A. occidentale), S4 (C. papaya), S5 (C. cajan), S6 (C. sinensis), S7 (E. caryophyllata), S8 (M. charantia) and S9 (P. guajava) recorded strong antioxidant activities enzymatically and non-enzymatically, thus bestowed promising antioxidant and in vitro antisickling effects.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Medicinal Plants - International Journal of Phytomedicines and Related Industries
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.